Immunological Monitoring During Anti-CD20 Therapies to Predict Infection Risk and Treatment Response in Multiple Sclerosis Patients - Iglesias, GT; Martínez-Feito, A; Otero-Ortega, L; Lopez-Molina, M; Puertas, I; Gonzalez-Torbay, A; Rita, CG; Fernández-Fournier, M; Velasco, SS; Chamorro, B; Díez-Tejedor, E; Lopez-Granados, E (Diseases, 2025)